ID
45967
Beskrivning
Principal Investigator: Jennifer R. Brown, Dana-Farber Cancer Institute, Broad Institute, Boston, MA, USA MeSH: Leukemia, Lymphocytic, Chronic, B-Cell https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000879 Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by accumulation of CD5+CD19+ B cells in peripheral lymphoid organs, bone marrow and blood. In this study we analyze matched whole genome sequencing and RNA-seq data from CLL patients to characterize the mutational processes operative throughout tumor evolution. Source of tumor and normal DNA used is patient PBMC or B cells and saliva respectively.
Länk
Nyckelord
Versioner (1)
- 2024-03-26 2024-03-26 - Madita Rudolph
Rättsinnehavare
Jennifer R. Brown, Dana-Farber Cancer Institute, Broad Institute, Boston, MA, USA
Uppladdad den
26 mars 2024
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000879 DFCI Brown Lab CLL Sequencing Study
Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- StudyEvent: SEV1
- Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
Similar models
Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- StudyEvent: SEV1
- Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
C0441833 (UMLS CUI [1,2])
C0242481 (UMLS CUI [1,2])